RTTNews) – Bayer announced the submission of an application to the European Medicines Agency for the oral androgen receptor inhibitor darolutamide. The company is seeking approval for the use of darolutamide in combination with androgen deprivation therapy in patients with metas…
Read More
Related Posts
Relic from Bay Area family washes ashore in Australia, dumbfounding locals
Access to this page has been denied Read More
California heat wave updates: Yosemite Valley poised to get as hot as 109
Get the latest on a heat wave bringing sizzling temperatures to California this week…Read More
7 fabulous photos of Nicola Coughlan from the Bridgerton red carpet events
The first four episodes of Bridgerton’s third season dropped in May, and it’s been a brutally long wait to find out what happens between the […]